{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-1-756.6","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-1-756.6","heading":"Informed consent required","body":"A. No abortion-inducing drug shall be provided without the\n\ninformed consent of the pregnant woman as described in this section\n\nto whom the abortion-inducing drug is provided.\n\nB. Informed consent to a chemical abortion shall be obtained at\n\nleast seventy-two (72) hours before the abortion-inducing drug is\n\nprovided to the pregnant woman, except if in reasonable medical\n\njudgment, compliance with this subsection would pose a greater risk\n\nof:\n\n1. The death of the pregnant woman; or\n\n2. The substantial and irreversible physical impairment of a\n\nmajor bodily function not including psychological or emotional\n\nconditions, of the pregnant woman.\n\nC. A form created by the State Department of Health shall be\n\nused by a qualified physician to obtain the consent required prior\n\nto providing an abortion-inducing drug.\n\nD. A consent form is not valid and consent is not sufficient,\n\nunless:\n\n1. The patient initials each entry, list, description or\n\ndeclaration required to be on the consent form as detailed in\n\nparagraphs 1 through 6 of subsection E of this section;\n\n2. The patient signs the \"consent statement\" described in\n\nparagraph 11 of subsection E of this section; and\n\n3. The qualified physician signs the \"qualified physician\n\ndeclaration\" described in paragraph 12 of subsection E of this\n\nsection.\n\nE. The consent form shall include, but is not limited to, the\n\nfollowing:\n\n1. The probable gestational age of the unborn child as\n\ndetermined by both patient history and by ultrasound results used to\n\nconfirm gestational age;\n\n2. A detailed description of the steps to complete the chemical\n\nabortion;\n\n3. A detailed list of the risks related to the specific\n\nabortion-inducing drug or drugs to be used including, but not\n\nlimited to, hemorrhaging, failure to remove all tissue of the unborn\n\nchild which may require an additional procedure, sepsis, sterility\n\nand possible continuation of pregnancy;\n\n4. Information about Rh incompatibility including that if she\n\nhas an Rh-negative blood type, she should receive an injection of Rh\n\nimmunoglobulin at the time of the abortion to prevent Rh\n\nincompatibility in future pregnancies;\n\n5. That the risks of complications from a chemical abortion\n\nincluding incomplete abortion, increase with advancing gestational\n\nage;\n\n6. That it may be possible to reverse the effects of the\n\nchemical abortion should she change her mind, but that time is of\n\nthe essence;\n\n7. That she may see the remains of her unborn child in the\n\nprocess of completing the abortion;\n\n8. That initial studies suggest that children born after\n\nreversing the effects of Mifeprex/mifepristone have no greater risk\n\nof birth defects than the general population;\n\n9. That initial studies suggest there is no increased risk of\n\nmaternal mortality after reversing the effects of\n\nMifeprex/mifepristone;\n\n10. That information on and assistance with reversing the\n\neffects of abortion-inducing drugs are available in the state-\n\nprepared materials;\n\n11. An \"acknowledgment of risks and consent statement\" which\n\nshall be signed by the patient. The statement shall include, but is\n\nnot limited to, the following declarations, which shall be\n\nindividually initialed by the patient:\n\na. that the patient understands that the abortion-\n\ninducing drug regimen or procedure is intended to end\n\nher pregnancy and will result in the death of her\n\nunborn child,\n\nb. that the patient is not being forced to have an\n\nabortion, that she has the choice not to have the\n\nabortion and that she may withdraw her consent to the\n\nabortion-inducing drug regimen even after she has\n\nbegun the abortion-inducing drug regimen,\n\nc. that the patient understands that the chemical\n\nabortion regimen or procedure to be used has specific\n\nrisks and may result in specific complications,\n\nd. that the patient has been given the opportunity to ask\n\nquestions about her pregnancy, the development of her\nt she may withdraw her consent to the\n\nabortion-inducing drug regimen even after she has\n\nbegun the abortion-inducing drug regimen,\n\nc. that the patient understands that the chemical\n\nabortion regimen or procedure to be used has specific\n\nrisks and may result in specific complications,\n\nd. that the patient has been given the opportunity to ask\n\nquestions about her pregnancy, the development of her\n\nunborn child, alternatives to abortion, the abortion-\n\ninducing drug or drugs to be used and the risks and\n\ncomplications inherent to the abortion-inducing drug\n\nor drugs to be used,\n\ne. that she was specifically told that \"Information on\n\nthe potential ability of qualified medical\n\nprofessionals to reverse the effects of an abortion\n\nobtained through the use of abortion-inducing drugs is\n\navailable at www.abortionpillreversal.com, or you can\n\ncontact (877) 558-0333 for assistance in locating a\n\nmedical professional that can aide in the reversal of\n\nan abortion.\",\n\nf. that she has been provided access to state-prepared,\n\nprinted materials on informed consent for abortion and\n\nthe state-prepared and maintained website on informed\n\nconsent for abortion,\n\ng. if applicable, that she has been given the name and\n\nphone number of the associated physician who has\n\nagreed to provide medical care and treatment in the\n\nevent of complications associated with the abortion-\n\ninducing drug regimen or procedure,\n\nh. that the qualified physician will schedule an in-\n\nperson follow-up visit for the patient at\n\napproximately seven (7) to fourteen (14) days after\n\nproviding the abortion-inducing drug or drugs to\n\nconfirm that the pregnancy is completely terminated\n\nand to assess the degree of bleeding and other\n\ncomplications, and\n\ni. that the patient has received or been given sufficient\n\ninformation to give her informed consent to the\n\nabortion-inducing drug regimen or procedure, and\n\nj. that the patient has a private right of action to sue\n\nthe qualified physician under the laws of this state\n\nif she feels that she has been coerced or misled prior\n\nto obtaining an abortion, and how to access state\n\nresources regarding her legal right to obtain relief;\n\nand\n\n12. A \"qualified physician declaration\", which shall be signed\n\nby the qualified physician, stating that the qualified physician has\n\nexplained the abortion-inducing drug or drugs to be used, has\n\nprovided all of the information required in subsection E of this\n\nsection, and has answered all of the woman's questions.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"1d6b32a51bd0d3d3d791a4359f100cf0d0acf78d0b256f82acbd7d5f06beabf0","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-1-756.5","next":"us-ok/okla.-stat.-tit.-63-63-1-756.7"},"notice":"GroundRules: Original legal text. Not legal advice."}